Gilead Data on Breast Cancer Drug Is ‘Surprise Win,’ Analyst Says

Gilead Data on Breast Cancer Drug Is ‘Surprise Win,’ Analyst Says
·1 min read

Gilead announced Monday that the overall survival rate for patients taking the drug had achieved statistical significance.